Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Surgical approach to the locoregional recurrence of cancer of the rectum
Journal Information
Vol. 89. Issue 5.
Pages 269-274 (May 2011)
Share
Share
Download PDF
More article options
Vol. 89. Issue 5.
Pages 269-274 (May 2011)
Full text access
Surgical approach to the locoregional recurrence of cancer of the rectum
Abordaje quirúrgico de la recidiva locorregional del cáncer de recto
Visits
1498
Aintzane Lizarazu, José M. Enríquez-Navascués
Corresponding author
, Carlos Placer, Alberto Carrillo, Aitor Sainz-Lete, José L. Elósegui
Unidad de Cirugía Colorrectal. Servicio de Cirugía General y Digestiva, Hospital Donostia, San Sebastián, Spain
This item has received
Article information
Abstract

A literature review has been made on the pelvic recurrence of rectal cancer using the MedLine, Ovid, EMBASE, Cochrane and Cinahl data bases. Assessment of the locoregional recurrence must be made using imaging tests in order to rule out the presence of metastasis, as well as for locating its exact location within the pelvis. As the only curative treatment should be complete resection of the recurrence with negative margins, a pre-operative CT, NMR, endorectal ultrasound and PET-CT must be performed to determine its resectability. For a potential cure, radical resections must be made, with the technique varying according to whether the location is central (axial), posterior (presacral) or lateral, as well as treatment directed at the primary tumour. Neoadjuvant treatments, brachiterapy and intra-operative radiotherapy improve the local control results and survival in these patients.

Keywords:
Rectal cancer
Recurrent rectal cancer
Radical surgery
Resumen

Se ha realizado una revisión literaria relativa a la cirugía de la recurrencia pélvica del cáncer de recto utilizando las bases de datos MedLine, Ovid, EMBASE, Cochrane y Cinahl. La evaluación por pruebas de imagen de la recidiva locorregional debe realizarse tanto para descartar la presencia de metástasis como con el objetivo de localizar el sitio preciso (subsitio) de la misma dentro de la pelvis. Como el único tratamiento curativo será la resección completa de la recidiva con márgenes negativos, se deben realizar preoperatoriamente TC, RMN, ecografía endorrectal y PET-TC para determinar la resecabilidad. Para una potencial curación, se deben realizar resecciones radicales, variando la técnica según la localización de la recurrencia sea central (axial), posterior (presacra) o lateral, así como el tratamiento efectuado del tumor primario. Los tratamientos neoadyuvantes, la braquiterapia y la RTIO mejoran los resultados de control local y la supervivencia en estos pacientes.

Palabras clave:
Cáncer de recto
Cáncer de recto recurrente
Cirugía radical
Full text is only aviable in PDF
References
[1.]
P. Bouchard, J. Efron.
Management of recurrent rectal cancer.
Ann Surg Oncol, 17 (2010), pp. 1343-1356
[2.]
A.M. Abulafi, N.S. Williams.
Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy.
Br J Surg, 81 (1995), pp. 7-19
[3.]
P.M. Sagar, J.H. Pemberton.
Surgical management of locally recurrent rectal cancer.
Br J Surg, 83 (1996), pp. 293-304
[4.]
F.T.J. Ferenschid, M. Vermaas, C. Verhof, R.S. Dwarkasing, A.M.M. Eggermont, J.H.W. De Wilt.
Abdominosacral resection for locally advanced and recurrent rectal cancer.
Br J Surg, 96 (2009), pp. 1341-1347
[5.]
M. Kusters, C. Wallner, M.M. Lange, M.C. DeRuiter, C.J.H. Van de Velde, Y. Moriya, et al.
Origin of presacral local recurrence after rectal cancer treatment.
Br J Surg, 97 (2010), pp. 1582-1587
[6.]
M. Kusters, C.A. Marijnen, L.J. Van de Velde, H.J. Rutten, M.J. Lahaye, J.H. Kim, et al.
Patterns of local recurrence in rectal cancer;a study of the Dutch TME trial.
Eur J Surg Oncol, 36 (2010), pp. 470-476
[7.]
G. Palmer, A. Martling, B. Cedermark, T. Holm.
A populationbased study on the management and outcome in patients with locally recurrent rectal cancer.
Ann Surg Oncol, 14 (2007), pp. 447-454
[8.]
D. Hahnloser, H. Nelson, L.L. Gunderson, I. Hassan, M.G. Haddock, M.J. O’Connell.
Curative potential of multimodality therapy for locally recurrent rectal cancer.
[9.]
H.G. Moore, M. Shoup, E. Riedel, B.D. Minsky, K.M. Alektiar, M. Ercolani, et al.
Colorectal cancer pelvic recurrences: determinants of resecability.
Dis Colon Rectum, 47 (2004), pp. 1599-1606
[10.]
A.H. Mirnezami, P.M. Sagar, D. Kavanagh, D. Witherspoon, P. Lee, P. Winter.
Clinical algorithms for the surgical management of locally recurrent rectal cancer.
Dis Colon Rectum, 53 (2010), pp. 1248-1257
[11.]
A.G. Heriot, C.M. Byrne, P. Lee, H. Forbes, M.R. Thompson, J.D. Stamatakis, et al.
Extended radical resection: the choice for locally recurrent rectal cancer.
Dis Colon Rectum, 51 (2008), pp. 284-291
[12.]
J. Hartley, R. Lopez, P.B. Paty, W.D. Wong, A.M. Cohen, J. Guillem.
Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified?.
Ann Surg Oncol, 10 (2003), pp. 227-233
[13.]
J. García-Aguilar, J.W. Cromwell, C. Marra, S.H. Lee, R.D. Madoff, D.A. Rothenberger.
Treatment of locally recurrent rectal cancer.
Dis Colon Rectum, 44 (2001), pp. 1743-1748
[14.]
G. Rontondano, P. Esposito, L. Pellecchia, A. Novi, G. Romano.
Early detection of locally recurrent rectal cancer by endosonography.
Br J Radiol, 70 (1997), pp. 567-571
[15.]
A. Siddiqui, Y. Fayiga, S. Huerta.
The role of endoscopic ultrasound in the evaluation of rectal cancer.
Int Semin Surg Oncol, 3 (2006), pp. 36-46
[16.]
R.G. Beets-Tan, G.L. Beets, A.C. Borstlap, T.K. Oei, T.M. Teune, M.F. Von Meyenfeldt, et al.
Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI?.
Abdom Imaging, 25 (2000), pp. 533-541
[17.]
O. Schaefer, M. Langer.
Detection of recurrent rectal cancer with CT.
MRI and PET/CT. Eur Radiol, 17 (2007), pp. 2044-2054
[18.]
C. Messiou, A. Chalmers, K. Boyle, D. Wilson, P. Sagar.
Preoperative MR assessment of recurrent rectal cancer.
Br J Radiol, 966 (2008), pp. 468-473
[19.]
J. Votrubova, O. Belohlavek, M. Jaruskova.
The role of FDG-PET/CT in the detection of recurrent rectal cancer.
Eur J Nucl Med Mol Imaging, 33 (2006), pp. 779-784
[20.]
H. Moore, T. Akhurst, L.M. Larson, B.D. Minsky, M. Mazumdar, J.G. Guillem.
A case-controlled study of 18-fluorodeoxyglucose in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
J Am Coll Surg, 197 (2003), pp. 22-28
[21.]
P. Schurr, E. Lentz, S. Block, J. Kaifi, H. Kleinhans, G. Cataldegirmen, et al.
Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience.
J Gastrointest Surg, 12 (2008), pp. 1232-1238
[22.]
Y. Moriya, T. Akasu, S. Fujita, et al.
Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis.
Dis Colon Rectum, 47 (2004), pp. 2047-2050
[23.]
R.C. Dresen, M.J. Gosens, H. Martijn, G.A. Nieuwenhuijzen, G.J. Creemers.
Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.
Ann Surg Oncol, 15 (2008), pp. 1937-1947
[24.]
D. Sebag-Montefiore, R.J. Stephens, R. Steele, J. Monson, R. Grieve, S. Khanna, et al.
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.
[25.]
V. Valentini, A.G. Morganti, M.A. Gambacorta, M. Mohiuddin, G.B. Doglietto, C. Coco, et al.
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study.
Int J Radiat Oncol Biol Phys, 64 (2006), pp. 1129-1139
[26.]
M. Mohiuddin, G. Marks, J. Marks.
Long-term results of reirradiation for patients with recurrent rectal carcinoma.
Cancer, 95 (2002), pp. 1144-1150
[27.]
J. Kuehne, T. Kleisli, P. Biernacki, M. Girvigian, O. Streeter, M.L. Corman, et al.
Use of high dose-rate brachitherapy in the management of locally recurrent rectal cancer.
Dis Colon Rectum, 46 (2003), pp. 895-899
[28.]
A. Sun Myint, T. Mukhopadhyay, V.S. Ramani, K. Perkins, A.J. Snee, F. Jelley, et al.
Can increasing the dose of radiation by HDR brachitherapy boost following preoperative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?.
Colorectal Dis, 12 (2010), pp. 30-36
[29.]
C.G. Willet, B.G. Czito, D.S. Tyler.
Intraoperative radiation therapy.
Clin J Oncol, 25 (2007), pp. 971-977
[30.]
M. Vermaas, J.J. Nuyttens, F.T. Ferenschild, C. Cornelis Verhoef, A.M.M. Eggermont, De Wilt JHWAT.
Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients.
Radiother Oncol, 87 (2008), pp. 357-360
[31.]
C. Moreno-Sanz, M. Manzanera-Díaz, M. Clerveus, F.J. Cortina- Oliva, J. De Pedro-Conal, J. Picazo-Yeste.
Reconstrucción pélvica tras amputación abdominoperineal del recto.
Cir Esp, (2010),
[32.]
J.E. Casal Núñez, N. Cáceres Alvarado, A. De Sanildefonso Pereira, M.B. Toscano Novelle, M.A. García Martínez, P. Jove Albores.
Resección abdominoperineal en cáncer anal: reconstrucción del periné con colgajo miocutáneo de músculo recto anterior abdominal.
Cir Esp, (2010),
[33.]
E. Radice, H. Nelson, S. Mercill.
Primary myocutaneous flap closure following resection of locally advanced pelvic malignancies.
[34.]
D. Shibata, W. Hyland, P. Busse, H.K. Kim, S.T. Sentovich, G. Steele.
Immediate reconstruction of the perineal wound with gracilis muscle flaps following abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma of the rectum.
Ann Surg Oncol, 6 (1999), pp. 33-37
[35.]
Golda T, Biondo S, Kreisler E, Frago R, Fraccalvieri D, Millan M. Follow-up of double-barreled wet colostomy after pelvic exenteration at a single institution. Dis Colon Rectum.
Copyright © 2011. Asociación Española de Cirujanos
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos